Louis Renzetti Email

Chief Scientific Officer . Bridge Medicines

Current Roles

Employees:
4
Revenue:
$402k
About
Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Our mission is to move breakthrough research to the patient by bringing the best in modern drug discovery to the service of academic medicine.
Bridge Medicines Address
780 Third Avenue
New York, NY
United States
Bridge Medicines Email

Past Companies

Bridge MedicinesChief Scientific Officer
Fairleigh Dickinson UniversityAdjunct Professor, Medco School of Pharmacy
Gotham TherapeuticsHead of Research and Early Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.